Letermovir as a Rescue Therapy in Kidney Transplant Recipients with Valganciclovir/Ganciclovir Refractory/Resistant Cmv Disease

被引：0
|
作者：
von Hoerschelmann, E. [1 ]
Gao, L. [1 ]
Luecht, C. [1 ]
Muench, J. [1 ]
Naik, M. G. [1 ]
Schmidt, D. [1 ]
Weber, U. [1 ]
Choi, M. [1 ]
Halleck, F. [1 ]
Budde, K. [1 ]
机构：
[1] Charite, Nephrol, Berlin, Germany
来源：
AMERICAN JOURNAL OF TRANSPLANTATION | 2023年 / 23卷 / 06期
关键词：
D O I：
暂无
中图分类号：
R61 [外科手术学];
学科分类号：
摘要：
D130
引用
收藏
页码：S1118 / S1118
页数：1
相关论文
共 50 条
  • [31] Valganciclovir approved for the prevention of CMV in high-risk kidney, kidney-pancreas transplant recipients
    不详
    DIALYSIS & TRANSPLANTATION, 2003, 32 (11) : 646 - 646
  • [32] Letermovir For The Treatment And Secondary Prophylaxis Of Drug Resistant CMV In Solid Organ Transplant Recipients.
    Pereira, M. R.
    Aaron, J. G.
    Kubin, C. J.
    AMERICAN JOURNAL OF TRANSPLANTATION, 2019, 19 : 459 - 460
  • [33] The emergence of cytomegalovirus resistance to ganciclovir therapy in kidney transplant recipients
    Nogueira, Eliana
    Ozaki, Kikumi S.
    Tomiyama, Helena
    Granato, Celso F. H.
    Camara, Niels O. S.
    Pacheco-Silva, Alvaro
    INTERNATIONAL IMMUNOPHARMACOLOGY, 2006, 6 (13-14) : 2031 - 2037
  • [34] Preemptive Therapy Versus Valganciclovir Prophylaxis in CMV R plus Kidney Transplant Recipients Receiving Antithymocyte Globulin Induction
    Couzi, L.
    Helou, S.
    Bachelet, T.
    Martin, S.
    Moreau, K.
    Morel, D.
    Lafon, M. -E.
    Garrigue, I.
    Merville, P.
    AMERICAN JOURNAL OF TRANSPLANTATION, 2012, 12 : 469 - 469
  • [35] Valganciclovir is safe and effective for CMV prophylaxis in kidney and pancreas transplant recipients who receive antilymphocyte antibody therapy.
    Baillie, GM
    Ashcraft, E
    Taber, D
    Afzal, F
    Rogers, J
    Lin, A
    Emovon, O
    Rajagopalan, PR
    Baliga, P
    Chavin, K
    JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2003, 14 : 426A - 426A
  • [36] CMV infection and CMV disease in kidney transplant recipients - our experience
    Chrastina, N.
    Zilinska, Z.
    Breza, J., Jr.
    Breza, J.
    BRATISLAVA MEDICAL JOURNAL-BRATISLAVSKE LEKARSKE LISTY, 2008, 109 (01): : 42 - 42
  • [37] CMV infection and CMV disease in kidney transplant recipients - our experiences
    Chrastina, M.
    Zilinska, Z.
    Breza, J.
    Breza, J., Jr.
    BRATISLAVA MEDICAL JOURNAL-BRATISLAVSKE LEKARSKE LISTY, 2008, 109 (05): : 246 - 246
  • [38] An RCT of ganciclovir prophylaxis for CMV disease in pediatric liver transplant recipients.
    King, SM
    Superina, R
    Andrews, W
    Winston, D
    Dunn, S
    Colombani, P
    CLINICAL INFECTIOUS DISEASES, 1996, 23 (04) : 243 - 243
  • [39] A prospective assessment of valganciclovir for the treatment of cytomegalovirus (CMV) infection and disease in transplant recipients.
    Humar, A
    Moussa, G
    Mazzulli, T
    Siegal, D
    Kumar, D
    AMERICAN JOURNAL OF TRANSPLANTATION, 2005, 5 : 385 - 385
  • [40] Comparison of Outcomes in Heart Transplant Recipients Receiving CMV Prophylaxis with CMV IVIG with Valganciclovir versus Valganciclovir Alone
    Moss, I.
    Brueckner, A.
    Rumore, A.
    JOURNAL OF HEART AND LUNG TRANSPLANTATION, 2020, 39 (04): : S480 - S480
12345